Transcription of Guideline - ESGE
{{id}} {{{paragraph}}}
GuidelineManagement of epithelial precancerous conditions and lesions inthe stomach (MAPS II): European Society of GastrointestinalEndoscopy (ESGE), EuropeanHelicobacterand Microbiota StudyGroup (EHMSG), European Society of Pathology (ESP), andSociedade portuguesa de Endoscopia Digestiva (SPED) guidelineupdate 2019 AuthorsPedro Pimentel-Nunes1,2,3, Diogo Lib nio1,2, Ricardo Marcos-Pinto2,4, Miguel Areia2,5,MarcisLeja6,Gianluca Esposito7, Monica Garrido4, Ilze Kikuste6, Francis Megraud8, Tamara Matysiak-Budnik9, Bruno Annibale7,Jean-Marc Dumonceau10, Rita Barros11,12,Jean-Fran oisFl jou13, F tima Carneiro11,12,14, Jeanin E. van Hooft15,Ernst J. Kuipers16, Mario Dinis-Ribeiro1,2 Institutions1 Gastroenterology Department, Portuguese OncologyInstitute of Porto, Portugal2 Center for Research in Health Technologies andInformation Systems (CINTESIS), Faculty of Medicine,Porto, Portugal3 Surgery and Physiology Department, Faculty ofMedicine of the University of Porto, Porto, Portugal,4 Department of Gastroenterology, Porto UniversityHospital Centre, Institute of Biomedical Sciences,University of Porto (ICBAS/UP), Portugal5 Gastroenterology Department, Portuguese OncologyInstitute of Coimbra, Portugal6 Institute of Clinical and Preventive Medicine, Universityof Latvia, Digestive Diseases Center, GASTRO, Riga,Latvia7 D
(ESGE), the Sociedade Portuguesa de Endoscopia Digestiva (SPED), the European Helicobacter and Microbiota Study Group (EHMSG), and the European Society of Pathology (ESP) pro-duced the first international guideline on the management of precancerous conditions and lesions in the stomach (MAPS) [4, 5].
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}